Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China flag China · Delayed Price · Currency is CNY
8.14
+0.15 (1.88%)
Jul 16, 2025, 2:45 PM CST

Tonghua Dongbao Pharmaceutical Company Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

It offers human insulin API and injections; insulin glargine API and injections; insulin aspart API and injections; liraglutide injections; zhennaoning capsules; and diabetes-related medical devices.

The company also provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system.

In addition, it offers chemical drugs, such as repaglinide and empagliflozin tablets. Further, the company offers building materials, including plastic steel windows and profiles; and engages in the real estate industry.

Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.

Tonghua Dongbao Pharmaceutical Co., Ltd.
CountryChina
Founded1985
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees3,410
CEOChun Sheng Leng

Contact Details

Address:
Dongbao New Village
Tonghua, 134123
China
Phone86 43 5508 8025
Websitethdb.com

Stock Details

Ticker Symbol600867
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE000000H87
SIC Code2834

Key Executives

NamePosition
Chun Sheng LengVice Chairman and GM
Junyu ChiChief Accountant
Guodong ZhangDeputy GM and Director
Wenhai ZhangDeputy GM and Director
Fan SuBoard Secretary